Healthcare AI Acquisition in a supplemental proxy filing today said it entered into a share purchase agreement with Atticus Ale. The sponsor will transfer 3,184,830 founder shares to the purchaser as part of the sponsor handover. The transfer is contingent on the approval of the extension proposals. If those are approved, the closing of the transfer is expected to take place June 12.
The SPAC wants to extend its termination deadline in monthly increments up to June 14, 2024.
Healthcare AI Acquisition raised $200 million in a December 2021 IPO. The company has been focused on businesses in the healthcare and pharmaceutical industry, specifically companies within the e-Clinical, Healthcare Information Technology or Outsourced Pharmaceutical Services industries with high AI readiness and technological transformation potential. Read more.
